Navios Flow Cytometer Cleared for Diagnostic Use in US and China
News Oct 02, 2013
In the U.S., the Navios flow cytometer from Beckman Coulter Life Sciences is intended for immunophenotyping in conjunction with proprietary Navios tetra software and CYTO-STAT tetraCHROME reagents.
The Navios has additional capabilities to meet expanded research needs. It incorporates 12 detectors which include 10 fluorescence detectors and two light scattering detectors. Simultaneous measurements of integral, peak and width are available for all scatter measurements and up to 10 fluorescent parameters.
Ready to use, pre-optimized CYTO-STAT tetraCHROME reagents make sample preparation easy. A no-wash protocol reduces sample handling and increases laboratory safety. Beckman Coulter’s Navios tetra system, for simultaneous identification and enumeration of T, B and NK lymphocytes in whole blood, provides an easy-to-use solution for multicolor flow cytometric analysis of lymphocyte subsets as well as CD4+ and CD8+ T cell subsets ratios.
Navios software reports cellular characteristics such as size, granularity and phenotype and combines data in one automated, customized report with plots and formulas. A variety of reporting options are available. Easy integration with a variety of automated preparation devices and LIS-readiness offers secure, high-throughput results, even at the highest volumes.
Mario Koksch, vice president of Beckman Coulter Life Sciences’ Flow Cytometry Business Unit, explained: “Every aspect of the optics design of Navios increases application performance, sensitivity and resolution. These systems enhance flow laboratory efficiency by increasing productivity and improving the reliability and reproducibility of results, thus reducing the cost of flow cytometry testing.”
A new method of selectively binding proteins to nanoparticles has been published. The nanoparticles automatically recognize specific peptides, i.e. small proteins, and enter into highly selective binding with them. Among the model peptides which the researchers examined were amyloids. The researchers hope that the mechanism they have discovered might provide a new approach to treating diseases in which such deposits occur, such as Alzheimer’s disease.READ MORE
International Conference on Cell and Structural biology
Jul 15 - Jul 16, 2019
4th EuroSciCon Conference on Gynecologic Oncology and Reproductive Disorders
Jul 25 - Jul 26, 2019